氨酸AI:氨酸能系统集中,基于人工智能的应用程序用于药物发现
Natalia Łapińska1,2, Adam Pacławski1, Jakub Szlęk1
1Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.
Journal of chemical information and modeling
|January 30, 2024
概括
氨酸AI是一个免费的网络工具,可以预测分子对氨酸点的亲和力. 它通过评估药物特性 (如血脑屏障透) 来帮助药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 血清的系统是复杂的,需要先进的工具来开发药物.
- 准确地预测与血清素受体和载体的分子亲和力至关重要.
研究的目的:
- 介绍SerotoninAI,这是一款用于预测分子对血清激素标的亲和力的新型网络应用程序.
- 为研究人员提供一种可访问的工具来评估类似药物的特性.
主要方法:
- 氨酸AI利用分子结构 (SMILES) 来预测氨酸受体和输送物的pKi值.
- 该应用程序评估了血脑屏障的透和人类肠道吸收.
- 它使用Streamlit开发,具有直观的用户界面.
主要成果:
- 氨酸AI为关键的氨酸基标提供了pKi值的预测.
- 它提供了对基本药物属性的洞察,有助于早期药物开发.
- 该工具可以免费访问,无需注册或收费.
结论:
- 氨酸AI通过提供快速,准确的对氨酸位的亲和力预测来增强药物开发.
- 该应用程序使获取必不可少的药物发现工具变得民主化,支持全球研究工作.
- 它的开源性质促进了进一步的开发和整合.
相关概念视频
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
260
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
260
Antidepressant Drugs: Overview
490
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
490
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


